Skip to main content

Elizabeth Grammer

Equibles does not estimate personal net worth.

About Elizabeth Grammer

Elizabeth Grammer was last confirmed as Board Member at Sagimet Biosciences Inc. (SGMT) in a filing dated April 30, 2025. Ardelyx, Inc. reported in an 8-K filed December 17, 2025 that Elizabeth Grammer resigned as Chief Legal and Administrative Officer, effective December 31, 2025. Sagimet Biosciences Inc. reported in an 8-K filed June 10, 2025 that Elizabeth Grammer was appointed Class II director, effective June 9, 2025. The proxy statement of Ardelyx, Inc. reports total compensation of $2,303,617 for Elizabeth Grammer in fiscal 2025, including a base salary of $527,126. Disclosed compensation is on record for 6 fiscal years.

“On December 17, 2025, Elizabeth Grammer informed Ardelyx, Inc. (the "Company") of her resignation as the Company's Chief Legal and Administrative Officer, effective December 31, 2025 (the "Resignation Date").”
Ardelyx, Inc. Form 8-K, filed December 17, 2025 · Read the filing
“Each of Elizabeth Grammer and Beth Seidenberg, M.D. were elected to the Board to serve as Class II directors until the 2028 Annual Meeting of Stockholders and until their successors, if any, are elected or appointed, or their earlier death, resignation, retirement, disqualification or removal, as follows:”
Sagimet Biosciences Inc. Form 8-K, filed June 10, 2025 · Read the filing

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Ardelyx, Inc. (ARDX) $527,126 $2,303,617
2024 Ardelyx, Inc. (ARDX) $509,300 $2,973,306
2023 Ardelyx, Inc. (ARDX) $463,300 $1,630,871
2021 Ardelyx, Inc. (ARDX) $445,500 $1,734,063
2019 Ardelyx, Inc. (ARDX) $414,000 $791,408
2018 Ardelyx, Inc. (ARDX) $400,000 $1,694,156

Recent activity